[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334833-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334833-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","sphingolipids-in-prostate-cancer-prognosis-integrating-single-cell-and-bulk-sequencing","Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing","","Risk stratification and clarification of the prostate cancer tumor microenvironment are central to improving patient management. This study integrates prostate cancer single-cell sequencing data from pradcellatlas with bulk transcriptome data from TCGA. It applies dimensionality reduction clustering to capture single-cell heterogeneity, gene set enrichment using GO/KEGG for functional interpretation, and WGCNA to define key coexpression modules. Prognostic models are built with Cox and LASSO regression in R, and selected gene expression is validated by PCR.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sphingolipids-in-prostate-cancer-prognosis-integrating-single-cell-and-bulk-sequencing/334833/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sphingolipids-in-prostate-cancer-prognosis-integrating-single-cell-and-bulk-sequencing/334833.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data sources were used to integrate single-cell and bulk sequencing?","Question",{"text":63,"@type":64},"Single-cell sequencing data were obtained from the pradcellatlas website, and bulk transcriptome data were retrieved from the TCGA database.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was heterogeneity in the single-cell dataset analyzed?",{"text":68,"@type":64},"Dimensionality reduction cluster analysis was used to investigate heterogeneity in the single-cell sequencing data.",{"name":70,"@type":61,"acceptedAnswer":71},"What prognostic model was developed and how did it perform?",{"text":72,"@type":64},"A sphingolipid metabolism-focused prognostic model (SRSR) was constructed with five genes (FUS, MARK3, CHTOP, ILF3, ARIH2). The model stratified patients into high-risk and low-risk groups, with the high-risk group showing significantly worse prognosis and distinct immune microenvironment differences.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334833,1790125463,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 9  \nResearch Paper  \nSphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing  \nShan Zhou1, Li Sun1, Fei Mao2,3, Jing Chen1  \n1 Department of Ultrasound, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian City 223300, People’s Republic of China  \n2 Department of Urology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian City 223300, People’s Republic of China  \n3 Department of Urology, The Affiliated Huaian No. 1 People’s Hospital of Xuzhou Medical University, Huaian City 223300, People’s Republic of China  \nCorrespondence to: Jing Chen, Fei Mao; email: [cjmimi@yeah.net](cjmimi@yeah.net), [https://orcid.org/0009-0006-7435-7012](https://orcid.org/0009-0006-7435-7012); [maofeidoctor@njmu.edu.cn](maofeidoctor@njmu.edu.cn)  \nKeywords: prostate cancer, sphingolipid metabolism, tumor microenvironment, prognosis, single-cell sequencing  \nReceived: December 5, 2023 Accepted: March 26, 2024 Published: May 6, 2024  \nCopyright: © 2024 Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nBackground: Stratifying patient risk and exploring the tumor microenvironment are critical endeavors in prostate cancer research, essential for advancing our understanding and management of this disease.  \nMethods: Single-cell sequencing data for prostate cancer were sourced from the pradcellatlas website, while bulk transcriptome data were obtained from the TCGA database. Dimensionality reduction cluster analysis was employed to investigate heterogeneity in single-cell sequencing data. Gene set enrichment analysis, utilizing GO and KEGG pathways, was conducted to explore functional aspects. Weighted gene coexpression network analysis (WGCNA) identified key gene modules. Prognostic models were developed using Cox regression and LASSO regression techniques, implemented in R software. Validation of key gene expression levels was performed via PCR assays.  \nResults: Through integrative analysis of single-cell and bulk transcriptome data, key genes implicated in prostate cancer pathogenesis were identified. A prognostic model focused on sphingolipid metabolism (SRSR) was constructed, comprising five genes: “FUS,” “MARK3,” “CHTOP,” “ILF3,” and “ARIH2 .” This model effectively stratified patients into high-risk and low-risk groups, with the high-risk cohort exhibiting significantly poorer prognoses. Furthermore, distinct differences in the immune microenvironment were observed between these groups. Validation of key gene expression, exemplified by ILF3, was confirmed through PCR analysis.  \nConclusion: This study contributes to our understanding of the role of sphingolipid metabolism in prostate cancer diagnosis and treatment. The identified prognostic model holds promise for improving risk stratification and patient outcomes in clinical settings.  \nINTRODUCTION  \nProstate cancer ranks among the most prevalent cancers affecting men globally [1] . Its risk escalates significantly with age, being infrequent in men below  \n40 but increasingly prevalent among those over  \n65 years old [2] . Despite considerable progress in prostate cancer treatment, substantial limitations and challenges persist, contingent on cancer stage, aggressiveness, and patient variability. Notably, when  \n8031  \ntumor cells metastasize beyond the prostate, treatment options become more restricted. While hormone therapy and chemotherapy can help manage the disease, they often fall short of a cure, with the cancer eventually developing resistance to these treatments. In particular, some patients may experience resistance to hormone therapy (androgen deprivation therapy), evolving into castration-resistant prostate cance","cbCaita1IFVsOY70","https://ap.wps.com/l/cbCaita1IFVsOY70","pdf",2581653,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epidemiology and clinical challenges\n## Metabolic reprogramming and the tumor microenvironment","[{\"question\":\"What data sources were used to integrate single-cell and bulk sequencing?\",\"answer\":\"Single-cell sequencing data were obtained from the pradcellatlas website, and bulk transcriptome data were retrieved from the TCGA database.\"},{\"question\":\"How was heterogeneity in the single-cell dataset analyzed?\",\"answer\":\"Dimensionality reduction cluster analysis was used to investigate heterogeneity in the single-cell sequencing data.\"},{\"question\":\"What prognostic model was developed and how did it perform?\",\"answer\":\"A sphingolipid metabolism-focused prognostic model (SRSR) was constructed with five genes (FUS, MARK3, CHTOP, ILF3, ARIH2). The model stratified patients into high-risk and low-risk groups, with the high-risk group showing significantly worse prognosis and distinct immune microenvironment differences.\"}]","Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing | PDF",1790008495,33]